Zacks Research Analysts Raise Earnings Estimates for THC

Tenet Healthcare Corporation (NYSE:THC) – Investment analysts at Zacks Research raised their Q3 2026 earnings per share estimates for Tenet Healthcare in a report issued on Wednesday, February 25th. Zacks Research analyst Team now anticipates that the company will post earnings of $4.08 per share for the quarter, up from their prior estimate of $3.78. The consensus estimate for Tenet Healthcare’s current full-year earnings is $12.24 per share. Zacks Research also issued estimates for Tenet Healthcare’s Q4 2026 earnings at $4.44 EPS, Q1 2027 earnings at $4.31 EPS, Q2 2027 earnings at $4.75 EPS and FY2028 earnings at $17.80 EPS.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings results on Wednesday, February 11th. The company reported $4.70 EPS for the quarter, beating the consensus estimate of $4.08 by $0.62. The firm had revenue of $5.53 billion during the quarter, compared to analysts’ expectations of $5.47 billion. Tenet Healthcare had a return on equity of 26.33% and a net margin of 6.60%.The business’s quarterly revenue was up 8.9% compared to the same quarter last year. During the same period in the prior year, the firm posted $3.44 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS.

Other research analysts also recently issued research reports about the stock. UBS Group lifted their price objective on shares of Tenet Healthcare from $260.00 to $288.00 and gave the company a “buy” rating in a research report on Thursday, February 12th. Wells Fargo & Company reissued an “overweight” rating and set a $265.00 price target on shares of Tenet Healthcare in a research report on Monday, February 16th. KeyCorp raised their price objective on Tenet Healthcare from $225.00 to $250.00 and gave the company an “overweight” rating in a research report on Thursday, February 12th. Barclays boosted their target price on Tenet Healthcare from $240.00 to $257.00 and gave the stock an “overweight” rating in a report on Friday, February 13th. Finally, TD Cowen reaffirmed a “buy” rating on shares of Tenet Healthcare in a report on Thursday, February 12th. One investment analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, Tenet Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $247.67.

Tenet Healthcare Price Performance

NYSE:THC opened at $238.68 on Friday. The company has a current ratio of 1.76, a quick ratio of 1.68 and a debt-to-equity ratio of 2.18. The firm has a fifty day simple moving average of $206.02 and a 200 day simple moving average of $199.95. Tenet Healthcare has a 1-year low of $109.82 and a 1-year high of $240.83. The stock has a market capitalization of $20.76 billion, a PE ratio of 15.41, a P/E/G ratio of 1.18 and a beta of 1.44.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in THC. Dorsey Wright & Associates acquired a new stake in Tenet Healthcare during the fourth quarter worth approximately $10,750,000. Corient Private Wealth LLC grew its holdings in shares of Tenet Healthcare by 1,103.6% during the 4th quarter. Corient Private Wealth LLC now owns 45,847 shares of the company’s stock valued at $9,111,000 after purchasing an additional 42,038 shares during the last quarter. Mercer Global Advisors Inc. ADV increased its holdings in Tenet Healthcare by 24.4% in the 4th quarter. Mercer Global Advisors Inc. ADV now owns 42,180 shares of the company’s stock worth $8,382,000 after purchasing an additional 8,273 shares in the last quarter. Vident Advisory LLC raised its position in Tenet Healthcare by 6.3% during the 4th quarter. Vident Advisory LLC now owns 2,185 shares of the company’s stock worth $434,000 after purchasing an additional 129 shares during the last quarter. Finally, State of Tennessee Department of Treasury increased its position in shares of Tenet Healthcare by 0.6% during the fourth quarter. State of Tennessee Department of Treasury now owns 37,491 shares of the company’s stock worth $7,096,000 after buying an additional 223 shares during the period. 95.44% of the stock is owned by institutional investors.

Insider Buying and Selling at Tenet Healthcare

In other news, Director Nadja West sold 2,178 shares of the business’s stock in a transaction dated Monday, December 15th. The shares were sold at an average price of $197.47, for a total value of $430,089.66. Following the completion of the sale, the director owned 28,480 shares of the company’s stock, valued at approximately $5,623,945.60. The trade was a 7.10% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 0.81% of the company’s stock.

Tenet Healthcare News Roundup

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Zacks raised FY2026 EPS to $16.76 (from $15.41) — a meaningful upward revision to 2026 company-level earnings expectations. MarketBeat THC coverage
• Positive Sentiment: Q1 2026 EPS was increased to $4.14 (from $3.73), signalling stronger near-term operating performance. MarketBeat THC coverage
• Positive Sentiment: Q2 2026 EPS was raised to $4.10 (from $3.68), another near-term upward tweak. MarketBeat THC coverage
• Positive Sentiment: Zacks also lifted several quarterly 2026–2027 estimates (Q3 2026 to $4.08, Q4 2026 to $4.44, Q1 2027 to $4.31, and Q2 2027 slightly to $4.75), indicating expected stronger cadence through 2026 and into early 2027. MarketBeat THC coverage
• Positive Sentiment: Zacks published an FY2028 estimate of $17.80 EPS (new forward-year view), which supports a bullish longer-term earnings trajectory if achieved. MarketBeat THC coverage
• Negative Sentiment: Zacks cut FY2027 EPS to $16.35 from $17.98 — a notable decrease to next‑year full‑year expectations that can temper forward valuation. MarketBeat THC coverage
• Negative Sentiment: Q4 2027 was sharply lowered (to $3.28 from $4.82), representing the largest single-quarter downward revision and a driver of weaker medium-term visibility. MarketBeat THC coverage
• Negative Sentiment: Q3 2027 was reduced to $4.01 (from $4.38), another cut to later‑period quarterly expectations. MarketBeat THC coverage

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.